Loading Events
  • This event has passed.

« All Events

Dr. Thom Elston Presentation: Feature-based valuation and its impairment in psychiatric disease

July 7 @ 11:00 am - 12:00 pm

Part of the Summer Internship Speaker’s Series

Presenter: Dr. Thomas Elston

Bio: Dr. Thomas Elston is a systems neuroscientist interested in the neural foundations of cognitive control, which relates to our ability to align our behavior with our goals. The goal of his Lab is to understand how the prefrontal cortex interacts with other areas to facilitate aspects of cognitive control related to attention, decision-making and self-control in non-human primates. Through characterizing these mechanisms, the Elston Lab aims to create brain-computer interfaces that will enable scientists to directly interact with the physiology of cognition and improve the lives of people living with neurological disorders where cognitive control is impaired. Dr. Elston earned his Ph.D. in neuroscience from the University of Otago in Dunedin, New Zealand and, before joining UT Austin, was an Alexander von Humboldt Fellow at the University of Tübingen in Tübingen, Germany, and a postdoctoral fellow at the University of California, Berkeley.

Time: 11am to noon

Hybrid

Location: Health Discovery Building Rm 1.204 (in-person)

Register: https://bit.ly/43Df10M

 

Details

  • Date: July 7
  • Time:
    11:00 am - 12:00 pm

Organizer

  • Women in Neuroscience

Venue

Thanks to our investors and partners for supporting educational opportunities that lead to advancing brain health science and improved health outcomes.


Empowering students from under-resourced and underserved communities to pursue research and leadership pathways in neuroscience fields, ultimately contributing to advancing scientific innovation and improved health outcomes.

EIN: 85-4295528

© 2026 Women in Neuroscience, All rights reserved.

Winne Pak, PhD is a neuroscientist and clinical strategy expert with over two decades of experience in translational medicine, medical affairs, and program leadership across CNS and rare disease